ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis

ClinicalTrials.gov ID: NCT01860976

Public ClinicalTrials.gov record NCT01860976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept Subcutaneous Injection in Adults With Active Psoriatic Arthritis

Study identification

NCT ID
NCT01860976
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
489 participants

Conditions and interventions

Interventions

  • Abatacept Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 16, 2013
Primary completion
Jul 13, 2015
Completion
Jun 29, 2020
Last update posted
Apr 4, 2022

2013 – 2020

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
17
Facility City State ZIP Site status
Arizona Arthritis & Rheumatology Research PLLC Phoenix Arizona 85037
Arthritis Asso & Osteo Ctr Of Colorado Springs Colorado Springs Colorado 80920
Joao Nascimento Bridgeport Connecticut 06606
New England Research Associates, Llc Trumbull Connecticut 06611
Sarasota Arthritis Research Center Sarasota Florida 34239
Klein And Associates, M.D., Pa Hagerstown Maryland 21740
Tufts Medical Center Boston Massachusetts 02111
St. Paul Rheumatology, P.A. Eagan Minnesota 55121
Box Arthritis And Rheumatology Of The Carolinas, Pllc Charlotte North Carolina 28210
Paramount Medical Research & Consulting, Llc Middleburg Heights Ohio 44130
Health Research Of Oklahoma Oklahoma City Oklahoma 73103
East Penn Rheumatology Associates, P.C. Bethlehem Pennsylvania 18015
Clinical Research Center Of Reading, Llc Wyomissing Pennsylvania 19610
West Tennessee Research Institute Jackson Tennessee 38305
Rheumatology Consultants Pllc Knoxville Tennessee 37909-1907
Seattle Rheumatology Associates Seattle Washington 98122
Arthritis Northwest Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01860976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2022 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01860976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →